Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring

Aim: To compare in terms of glycemic variability two premixed insulins, Premixed Human Insulin 30/70 (PHI) and Biphasic Aspart 30 (BiAsp30), using Continuous Glucose Monitoring (CGM) and to estimate the correlation of Glycated Albumin (GA) and Fructosamine (FA) with CGM data. Patients-Data: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Margaritidis, Charalampos, Karlafti, Eleni, Kotzakioulafi, Evangelia, Kantartzis, Konstantinos, Tziomalos, Konstantinos, Kaiafa, Georgia, Savopoulos, Christos, Didangelos, Triantafyllos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125752/
https://www.ncbi.nlm.nih.gov/pubmed/34063071
http://dx.doi.org/10.3390/jcm10091982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125752/
https://www.ncbi.nlm.nih.gov/pubmed/34063071
http://dx.doi.org/10.3390/jcm10091982

Ejemplares similares